BOT 2.63% 37.0¢ botanix pharmaceuticals ltd

Ann: FDA Approves Sofdra, page-39

  1. 15,961 Posts.
    lightbulb Created with Sketch. 4171
    And look what happened to DXB...

    You need to give investors an incentive to participate in a cap raise, sometimes that's a big discount other times it's news that the market hasn't yet had time to react to. Works out the same really, except raising now before trading resumes removes the risk of a "sell the news" event forcing a lower cap raise at a large discount. Hopefully this opens the doors to fresh institutional investors who will help push this into the dollars
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
37.0¢
Change
-0.010(2.63%)
Mkt cap ! $669.7M
Open High Low Value Volume
38.0¢ 38.5¢ 36.5¢ $2.548M 6.766M

Buyers (Bids)

No. Vol. Price($)
2 96148 36.5¢
 

Sellers (Offers)

Price($) Vol. No.
37.0¢ 782479 9
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.